2022
DOI: 10.1002/oby.23561
|View full text |Cite
|
Sign up to set email alerts
|

Quantifying the phenome‐wide disease burden of obesity using electronic health records and genomics

Abstract: Objective: High BMI is associated with many comorbidities and mortality. This study aimed to elucidate the overall clinical risk of obesity using a genome-and phenomewide approach.Methods: This study performed a phenome-wide association study of BMI using a clinical cohort of 736,726 adults. This was followed by genetic association studies using two separate cohorts: one consisting of 65,174 adults in the Electronic Medical Records and Genomics (eMERGE) Network and another with 405,432 participants in the UK B… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 48 publications
1
0
0
Order By: Relevance
“…This nding primarily support that BMI would deserve more attention than genetic predisposition (for BMI) in preventing UG cancer. Moreover, the BMI variance explained by the PRS in TRAILS adolescents was 6.47% [30], and the genome-wide polygenic risk score for BMI accounting for 7.5% of BMI variance based on a clinical cohort of 736,726 adults [31]; both of them were either lower than or similar to the heritability (7%) of BMI reported in this study. We also observed a relatively obvious separation between actual BMI and genetically predicted BMI (Figure The potential separation would not only provide valuable insights into both genetic architecture and potential intervention of complex diseases and traits, but also deserve more attention in preventing UG cancer.…”
Section: Discussionsupporting
confidence: 69%
“…This nding primarily support that BMI would deserve more attention than genetic predisposition (for BMI) in preventing UG cancer. Moreover, the BMI variance explained by the PRS in TRAILS adolescents was 6.47% [30], and the genome-wide polygenic risk score for BMI accounting for 7.5% of BMI variance based on a clinical cohort of 736,726 adults [31]; both of them were either lower than or similar to the heritability (7%) of BMI reported in this study. We also observed a relatively obvious separation between actual BMI and genetically predicted BMI (Figure The potential separation would not only provide valuable insights into both genetic architecture and potential intervention of complex diseases and traits, but also deserve more attention in preventing UG cancer.…”
Section: Discussionsupporting
confidence: 69%